美国国家医学中心Arthur D. Riggs院士、Defu Zeng教授学术报告通知
发布时间: 2017-12-11 浏览次数: 10

美国国家医学中心Arthur D. Riggs院士、Defu Zeng教授学术报告通知


讲座时间:1212日(周二)下午200

讲座地点:玄武校区学术报告中心306

讲座一:A Journey: From Insulin and Antibodies   through Epigenetics to 3D Chromatin Structure.

主讲人:Arthur D. Riggs院士

讲座二:Induction of haploidentical mixed chimerism   for reversal of autoimmunity and augmentation of beta cell regeneration

主讲人:Defu Zeng教授

报告人简介:

http://www.cpu.edu.cn/_upload/article/images/4b/6c/2a677003456b8a93dc00aca79b9a/fa9e4ea4-603f-4461-9e8d-da1cf4e84236.jpg

Arthur D. Riggs院士简介

Arthur   D. RiggsPh.D, Professor.Samuel Rahbar Chair in Diabetes & Drug   Discovery

§Director, Diabetes   & Metabolism Research Institute at City of Hope

§Director Emeritus,   Beckman Research Institute of City of Hope

The   member of National Academy of Sciences(美国科学院院士).Department of Diabetes and Metabolic   Diseases Research, The Irell and Manella Graduate School of Biological   Sciences, Beckman Research Institute of City of Hope.

Dr.   Riggs is one of the most important founding scientists of modern epigenetics.

Dr.   Riggs’ invention of recombinant insulin (Humalin) has been used in clinic for   more than 20 years and has saved thousands of diabetic patients’ life as well   as jump-started modern biotechnology industry such as Genentech.

His   invention of humanized antibody technology is also saving thousands of cancer   patinents’ life.His patent loyalty brings $250 million a year to City of Hope   and facilitates the rapid development of City of Hope in the recent year.

Defu Zeng授简介

http://www.cpu.edu.cn/_upload/article/images/4b/6c/2a677003456b8a93dc00aca79b9a/a9ef2b45-428d-4318-95f1-40d3101d9f7f.jpg

Defu Zeng, MD,Professor,Departments of Diabetes Immunology and Hematopoietic Cell Transplantation  

Irell & Manella Graduate School of Biological Sciences of City of Hope.  

The Beckman Research Institute of City of Hope

City of Hope National Medical Center.

The research in Dr. Zeng’s lab has been   focused on transplantation immune tolerance. Dr. Zeng’s lab has been   dissecting the pathogenesis of acute and chronic graft versus host disease   (GVHD), separating graft versus leukemia/lymphoma (GVL) effect from GVHD, and   developing a radiation-free GVHD preventative regimen for induction of mixed   chimerism for the cure of autoimmune diseases such as type 1 diabetes,   multiple sclerosis, and systemic lupus.

Dr.   Zeng’s research is supported by NIH R01 grants and foundations and private   donations.

   Dr. Zeng has published more than 60   research articles in high impact journals, including Science Translational   Medicine, Proceedings of National Academy of Science (PNAS), Journal of   Experimental Medicine, Journal of Clinical Investigation, Blood, Diabetes,   and Journal of Immunology.

欢迎广大师生届时前往交流!

天然药物活性组分与药效国家重点实验室

天然药物活性组分与药效111基地

生命科学与技术学院

  2017122